Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies

Article Abstract:

The study evaluates the performance of a 1-stop clinic for first-trimester assessment of risk (OSCAR) for trisomy 21 by a combination of maternal age, fetal nuchal translucency (NT) thickness, and maternal serum-free beta-human chorionic gonadotrophin (hCG) and pregnancy-associated plasma protein-A (PAPP-A). It is concluded that the most effective method of screening for chromosomal defects is by first-trimester fetal NT and maternal serum biochemistry.

Author: Nicolaides, Kypros H., Spencer, Kevin, Avgidou, Kyriaki, Papageorghiou, Aris, Bindra, Renu
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2005
United States, Science & research, Research, Usage, Chorionic gonadotropin, Chorionic gonadotropins

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Nasal bone in first-trimester screening for trisomy 21

Article Abstract:

The impact of incorporating assessment of the nasal bone into first-trimester combined screening by fetal nuchal translucency (NT) thickness and material serum biochemistry is investigated. Results reveal that the inclusion of the nasal bone in first-trimester combined screening for trisomy 21 achieves a detection rate (DR) of 90% for a false-positive rate (FPR) of 2.5%.

Author: Nicolaides, Kypros H., Avgidou, Kyriaki, Cicero, Simona, Rembouskos, Georgios, Kagan, Karl Oliver
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2006
Diagnosis, Medical screening, Health screening, Disease/Disorder overview

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Sonographic screening for trisomy 13 at 11 to 13(super +6) weeks of gestation

Article Abstract:

A study with a purpose to examine the sonographic features of trisomy 13 at 11 to 13 (super +6) weeks of gestation was conducted. At the 11 to 13 (super +6) week scan, the measurement of fetal nuchal translucency and fetal heart rate and fetal examination for holoprosencephaly, exomphalos and megacystic can identify > 90% of fetuses with trisomy 13.

Author: Nicolaides, Kypros H., Spencer, Kevin, Avgidou, Kyriaki, Papageorghiou, Aris T., Nix, Barry
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2006
Measurement, Fetal heart rate, Prenatal diagnosis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Down syndrome
Similar abstracts:
  • Abstracts: More scrutiny for dietary supplements? Antidepressants and pregnancy. Suicide caution stamped on Antidepressants
  • Abstracts: Nurse's blunt message to prime minister speaks for the profession. The shocking truth about verbal abuse
  • Abstracts: Scientists seek simple remedies to cloning conundrums. Scientists, NIH in conflict over precious HIV samples. Stephen Lewis
  • Abstracts: Effects of anxiety, stress and neurotic disorders more severe than most injuries. Across the board
  • Abstracts: Alzheimer's APP mangles mitochondria. Merging mitochondria for neuronal survival. Less stress, longer life
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2023 Advameg, Inc.